跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
在 國立成功大學 搜尋內容
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
查看斯高帕斯 (Scopus) 概要
李 仁傑
Doctor
內科部
電子郵件
jclee508495
gmail
com
h-index
871
引文
18
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2012
2025
每年研究成果
概覽
指紋
網路
研究成果
(46)
類似的個人檔案
(6)
指紋
查看啟用 Jen-Chieh Lee 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Clostridium Difficile Infection
72%
Clinical Impact
36%
Risk Factors
36%
Difficile
30%
Clostridium Difficile-associated Diarrhea
25%
Southern Taiwan
23%
Ribotype 017
22%
Ribotype 078
22%
Odds Ratio
21%
Taiwan
21%
Ribotype 126
21%
Hospitalized Adults
21%
Clostridioides Difficile
21%
Hospitalized Patients
20%
Hospital-onset
19%
Azole-resistant Aspergillus Fumigatus
18%
Corticosteroid Therapy
18%
Nirmatrelvir
18%
Neutrophil Count
18%
Monkeypox
18%
COVID-19-associated Pulmonary Aspergillosis
18%
Rapid Species Identification
18%
Prognostic Factors
18%
White Blood Cells
18%
Clostridium Difficile Colonization
18%
Metronidazole
18%
Organism Identification
18%
Acute Stage
18%
Multicenter Prospective Study
18%
Clostridium Innocuum
18%
Non-culture Methods
18%
Emerging Zoonoses
18%
Infection Control Practitioners
18%
Neurospora Intermedia
18%
Endobronchial Mass
18%
Gut Carriage
18%
Symptomatic Cases
18%
Nucleotide-binding Domain
18%
Clostridioides Difficile Colonization
18%
Carbapenem-resistant Enterobacterales
18%
Clinical Role
18%
Co-infection
18%
Toxigenic
18%
TcdC
15%
TcdA
14%
TcdB
14%
Beta-lactamase Production
13%
Mating Type
13%
Toxinotype
12%
Confidence Interval
12%
Medicine and Dentistry
Infection
100%
Clostridium Difficile Infection
60%
Peptoclostridium difficile
48%
Dengue Fever
36%
Metronidazole
29%
Severe Dengue
24%
Diarrhea
23%
Klebsiella pneumoniae
21%
Emergency Department
20%
Extended Spectrum Beta Lactamase
20%
Prospective Study
20%
Mortality Rate
19%
Enterobacteriaceae
18%
COVID-19
18%
Mixed Infection
18%
Candidemia
18%
Nirmatrelvir
18%
Prognostic Factor
18%
Clostridium innocuum
18%
Antibiogram
18%
Hematologic Malignancy
18%
Urosepsis
18%
Bacterial Infection
18%
Corticosteroid Therapy
18%
Japanese Encephalitis
18%
Feces Culture
18%
Nursing Home
18%
Zoonosis
18%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
18%
Escherichia Coli Pneumonia
18%
Clinical Significance
18%
Health Care Facility
14%
Odds Ratio
12%
Antibiotic-Associated Diarrhea
10%
Retrospective Study
9%
Congestive Heart Failure
9%
Multilocus Sequence Typing
9%
Leukocyte
8%
Diseases
8%
Public Health
8%
Proton-Pump Inhibitor
8%
Vancomycin
8%
Multivariate Analysis
8%
Hospital Mortality
8%
Glasgow Coma Scale
7%
Cancer
7%
Escherichia coli
7%
Recurrence Risk
7%
Recurrent Disease
6%
Molecular Epidemiology
6%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
72%
Clostridium Difficile Infection
54%
Metronidazole
37%
Antiinfective Agent
37%
Dengue
36%
Diabetes Mellitus
23%
Prospective Study
23%
Disease Severity
21%
Mixed Infection
18%
Bloodstream Infection
18%
Monkeypox
18%
Candidemia
18%
Enterobacteriaceae
18%
Extended Spectrum Beta Lactamase
18%
Lung Aspergillosis
18%
Nirmatrelvir
18%
Bacterial Infection
18%
Clostridium butyricum
18%
Clostridium innocuum
18%
Viral Respiratory Tract Infection
18%
Pandemic
18%
Respiratory Virus
18%
Japanese Encephalitis
18%
Peptoclostridium difficile
16%
Diarrhea
14%
Antimicrobial Therapy
10%
Mortality Rate
10%
Smallpox Vaccine
9%
Congestive Heart Failure
9%
Retrospective Study
8%
Glasgow Coma Scale
7%
Matrix-Assisted Laser Desorption/Ionization
7%
Escherichia coli
7%
Monkeypox Virus
6%
Infectious Agent
6%
Respiratory Tract Infection
6%
Severe Dengue
6%
Heart Arrest
6%
Influenza Virus
6%
